Protom International, Inc., founded with the mission to revolutionize cancer treatment, focuses on expanding the accessibility of proton therapy. The company offers the Radiance 330® Proton Therapy System, a compact and modular solution designed to address challenges in cancer therapy. Protom International aims to make advanced proton therapy more economically viable and accessible to healthcare providers, primarily serving markets in Texas and Massachusetts.
Notable figures affiliated with Protom International include experts in medical technology and oncology. The company has achieved significant milestones, including the development and deployment of its innovative Radiance 330® system. Protom International's impact is evident in its contribution to making cutting-edge cancer treatment more accessible, thereby improving patient outcomes and advancing the field of proton therapy.
